Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in this nation for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and grown-ups . The medication functions as a prodrug, meaning it’s inactive until broken down by the body, dispensing dextroamphetamine